Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 2/20 | 0.38 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10495366 | 0.90 | — | — | |
| SCHEMBL18297988 | 0.90 | — | — | |
| SCHEMBL11778128 | 0.84 | TSHR (0.31) | TSHR | |
| SCHEMBL10078154 | 0.82 | TSHR (0.39) | TSHR | |
| SCHEMBL13066988 | 0.82 | TSHR (0.39) | TSHR | |
| SCHEMBL8487319 | 0.80 | TSHR (0.46) | TSHRHIF1AFAAHTRPV1 | |
| SCHEMBL690898 | 0.80 | TSHR (0.46) | TSHRHIF1AFAAHTRPV1 | |
| SCHEMBL13368624 | 0.79 | — | — | |
| SCHEMBL2610603 | 0.79 | — | — | |
| SCHEMBL886898 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11364200-B2 | — | — | 2022-06-21 | — | — | US | disclosed |
| US-11318099-B2 | — | — | 2022-05-03 | — | — | US | disclosed |
| CN-110637036-A | Compound having affinity substance, cleavable moiety and reactive group for soluble protein, or salt thereof | 味之素株式会社 | 2019-12-31 | — | — | CN | disclosed |
| US-20190133948-A1 | FUSOGENIC COMPOUNDS FOR DELIVERY OF BIOLOGICALLY ACTIVE MOLECULES | NITTO DENKO CORPORATION (JP) | 2019-05-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190133948-A1 | FUSOGENIC COMPOUNDS FOR DELIVERY OF BIOLOGICALLY ACTIVE MOLECULES | FUS, NSF, PGF | TSHR 4478/4885HIF1A 1064/4885FAAH 1061/4885 |
| US-11364200-B2 | — | FUS, NSF, MATR3 | TSHR 4775/4885HIF1A 1070/4885FAAH 896/4885 |
| US-11318099-B2 | — | FUS, NSF, MATR3 | TSHR 4775/4885HIF1A 1070/4885FAAH 896/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.